Cargando…
ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function
Both LRF (Zbtb7a) and ThPOK (Zbtb7b) belong to the POK (BTB/POZ and Kruppel) family of transcription repressors that participate in development, differentiation, and oncogenesis. Although LRF mediates osteoclast differentiation by regulating NFATc1 expression, the principal established function of T...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009119/ https://www.ncbi.nlm.nih.gov/pubmed/35434449 http://dx.doi.org/10.1002/jbm4.10613 |
_version_ | 1784687207699709952 |
---|---|
author | Zou, Wei Izawa, Takashi Rohatgi, Nidhi Zou, Steven Y Li, Yongjia Teitelbaum, Steven L |
author_facet | Zou, Wei Izawa, Takashi Rohatgi, Nidhi Zou, Steven Y Li, Yongjia Teitelbaum, Steven L |
author_sort | Zou, Wei |
collection | PubMed |
description | Both LRF (Zbtb7a) and ThPOK (Zbtb7b) belong to the POK (BTB/POZ and Kruppel) family of transcription repressors that participate in development, differentiation, and oncogenesis. Although LRF mediates osteoclast differentiation by regulating NFATc1 expression, the principal established function of ThPOK is transcriptional control of T‐cell lineage commitment. Whether ThPOK affects osteoclast formation or function is not known. We find that marrow macrophage ThPOK expression diminishes with exposure to receptor activator of NF‐kB ligand (RANKL), but ThPOK deficiency does not affect osteoclast differentiation. On the other hand, enhanced ThPOK, in macrophages, substantially impairs osteoclastogenesis. Excess ThPOK binds the NFATc1 promoter and suppresses its transcription, suggesting a mechanism for its osteoclast inhibitory effect. Despite suppression of osteoclastogenesis by excess ThPOK being associated with diminished NFATc1, osteoclast formation is not rescued by NFATc1 overexpression. Thus, ThPOK appears to inhibit NFATc1 transcription and its osteoclastogenic capacity, while its depletion has no effect on the bone‐resorptive cell. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. |
format | Online Article Text |
id | pubmed-9009119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90091192022-04-15 ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function Zou, Wei Izawa, Takashi Rohatgi, Nidhi Zou, Steven Y Li, Yongjia Teitelbaum, Steven L JBMR Plus Research Articles Both LRF (Zbtb7a) and ThPOK (Zbtb7b) belong to the POK (BTB/POZ and Kruppel) family of transcription repressors that participate in development, differentiation, and oncogenesis. Although LRF mediates osteoclast differentiation by regulating NFATc1 expression, the principal established function of ThPOK is transcriptional control of T‐cell lineage commitment. Whether ThPOK affects osteoclast formation or function is not known. We find that marrow macrophage ThPOK expression diminishes with exposure to receptor activator of NF‐kB ligand (RANKL), but ThPOK deficiency does not affect osteoclast differentiation. On the other hand, enhanced ThPOK, in macrophages, substantially impairs osteoclastogenesis. Excess ThPOK binds the NFATc1 promoter and suppresses its transcription, suggesting a mechanism for its osteoclast inhibitory effect. Despite suppression of osteoclastogenesis by excess ThPOK being associated with diminished NFATc1, osteoclast formation is not rescued by NFATc1 overexpression. Thus, ThPOK appears to inhibit NFATc1 transcription and its osteoclastogenic capacity, while its depletion has no effect on the bone‐resorptive cell. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. John Wiley & Sons, Inc. 2022-03-14 /pmc/articles/PMC9009119/ /pubmed/35434449 http://dx.doi.org/10.1002/jbm4.10613 Text en © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Zou, Wei Izawa, Takashi Rohatgi, Nidhi Zou, Steven Y Li, Yongjia Teitelbaum, Steven L ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function |
title |
ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function |
title_full |
ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function |
title_fullStr |
ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function |
title_full_unstemmed |
ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function |
title_short |
ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function |
title_sort | thpok inhibits osteoclast formation via nfatc1 transcription and function |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009119/ https://www.ncbi.nlm.nih.gov/pubmed/35434449 http://dx.doi.org/10.1002/jbm4.10613 |
work_keys_str_mv | AT zouwei thpokinhibitsosteoclastformationvianfatc1transcriptionandfunction AT izawatakashi thpokinhibitsosteoclastformationvianfatc1transcriptionandfunction AT rohatginidhi thpokinhibitsosteoclastformationvianfatc1transcriptionandfunction AT zousteveny thpokinhibitsosteoclastformationvianfatc1transcriptionandfunction AT liyongjia thpokinhibitsosteoclastformationvianfatc1transcriptionandfunction AT teitelbaumstevenl thpokinhibitsosteoclastformationvianfatc1transcriptionandfunction |